AFT PHARMACEUTICALS

AFT
End-of-day quote. End-of-day quote  - 03/02
4.2NZD +0.72%

Aft Pharmaceuticals : Posts Decline in Profit, Rise in Revenue for Six Months Ended September; Shares Down 5%

11/18/2020 | 06:43pm
(MT Newswires) -- Aft Pharmaceuticals (ASX:AFP, NZE:AFT) on Thursday reported attributable profit after tax of NZ$1.2 million ($820,000) for the six months ended Sept. 30, or NZ$0.01 per share, compared with NZ$9.9 million, or NZ$0.10 per share, a year earlier.

Revenue for the half-year rose year over year to NZ$48.8 million from NZ$46.9 million.

For fiscal 2021, the company expects operating profit to range from NZ$14 million to NZ$18 million, a 23% to 58% growth over FY20. The company said it will review its dividend policy in FY22 when debt returns to a satisfactory level.

Shares of the company were down nearly 5% in recent trading.

Price (AUD): $4.86, Change: $-0.24, Percent Change: -4.71%

© MT Newswires 2021
Copier lien
All news about AFT PHARMACEUTICALS LIMITED
01/18
12/22
12/14
11/19
11/18